—

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — the peer cohort

As of 2026-10-07 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Amneal Pharmaceuticals, Inc. Class A Common Stock ranks 6 of 11 in its cohort on the Closelooknet composite (55/100) — the cohort is led by DexCom Inc at 66/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 55 89 58 43 ok 7.2%
ROVI.MC Laboratorios Farmaceuticos ROVI 62 27 78 53 info 30.8%
ALM.MC Almirall S.A. 53 22 46 69 warn 25.6%
FAGR.BR Fagron NV 53 48 57 60 info 9.7%
APTX.TO Apotex Health Corp 47 35 59 51 — —
RDY Dr. Reddy’s Laboratories Ltd ADR 46 29 44 63 info 20.9%
SFZN.SW Siegfried Holding Ltd 42 28 45 55 info 31.8%
DXCM DexCom Inc 66 83 81 38 bear 9.9%
ONC BeiGene, Ltd. 64 81 65 32 ok 5.5%
MEDP Medpace Holdings Inc 63 81 75 30 ok 10.9%
PTGX Protagonist Therapeutics Inc 60 77 62 12 info 12.4%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-07

Quick answers

Who are Amneal Pharmaceuticals, Inc. Class A Common Stock's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Almirall S.A. (ALM.MC), Fagron NV (FAGR.BR), Apotex Health Corp (APTX.TO), Dr. Reddy’s Laboratories Ltd ADR (RDY), Siegfried Holding Ltd (SFZN.SW), DexCom Inc (DXCM), BeiGene, Ltd. (ONC) and others.

How does AMRX score against its peers?

Amneal Pharmaceuticals, Inc. Class A Common Stock's composite reads 55/100, ranking 6 of 11 in its cohort as of 2026-10-07; the cohort's highest composite is DexCom Inc at 66/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.